Angiopoietin receptor

Cell-surface receptors which bind angiopoietin
Angiopoietin receptor
Identifiers
SymbolTIE
PfamPF10430
InterProIPR018941
Membranome1214
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
Identifiers
SymbolTIE1
Alt. symbolsTIE, JTK14
NCBI gene7075
HGNC11809
OMIM600222
RefSeqNM_005424
UniProtP35590
Other data
EC number2.7.1.112
LocusChr. 1 p34-p33
Search for
StructuresSwiss-model
DomainsInterPro
TEK tyrosine kinase, endothelial
Identifiers
SymbolTEK
Alt. symbolsTIE2, TIE-2, VMCM1, CD202b
NCBI gene7010
HGNC11724
OMIM600221
RefSeqNM_000459
UniProtQ02763
Other data
LocusChr. 9 p21
Search for
StructuresSwiss-model
DomainsInterPro

The angiopoietin receptors are receptors that bind angiopoietin. TIE-1 and TIE-2 comprise the cell-surface receptors that bind and are activated by the angiopoietins, (Ang1, Ang2, Ang3, Ang4). The angiopoietins are protein growth factors required for the formation of blood vessels (angiogenesis).

Angiopoietins

The angiopoietins are protein growth factors that regulate angiogenesis, the formation of blood vessels. In humans, three angiopoietins have been identified: Ang1, Ang2, and Ang4 (Ang 3 is the mouse ortholog of human Ang4).[1] Ang1 and Ang4 function as agonistic or activating ligands for Tie2, whereas Ang2 and Ang3 behave as competitive antagonists. They function by binding their physiologic receptors, Tie-1 and Tie-2. These are receptor tyrosine kinases, so named because they mediate cell signals by inducing the phosphorylation of key tyrosines, thus initiating cell signalling.

It is somewhat controversial which of the Tie receptors mediate functional signals downstream of Ang stimulation. But it is clear that at least Tie-2 is capable of physiologic activation as a result of binding the angiopoietins.[citation needed]

See also

External links

References

  1. ^ Jeltsch M, Leppanen VM, Saharinen P, Alitalo K (2013). "Receptor Tyrosine Kinase-Mediated Angiogenesis". Cold Spring Harbor Perspectives in Biology. 5 (9): a009183. doi:10.1101/cshperspect.a009183. PMC 3753715. PMID 24003209.
  • v
  • t
  • e
Growth factor receptors
EGF receptor family
Insulin receptor family
PDGF receptor family
FGF receptor family
VEGF receptors family
HGF receptor family
Trk receptor family
EPH receptor family
LTK receptor family
TIE receptor family
ROR receptor family
DDR receptor family
PTK7 receptor family
RYK receptor family
MuSK receptor family
ROS receptor family
AATYK receptor family
AXL receptor family
RET receptor family
uncategorised
ABL family
ACK family
CSK family
FAK family
FES family
FRK family
JAK family
SRC-A family
SRC-B family
TEC family
  • TEC
  • BMX
  • BTK
  • ITK
  • TXK
SYK family
  • v
  • t
  • e
Angiopoietin
  • Kinase inhibitors: Altiratinib
  • CE-245677
  • Rebastinib
CNTF
EGF (ErbB)
EGF
(ErbB1/HER1)
ErbB2/HER2
  • Agonists: Unknown/none
ErbB3/HER3
ErbB4/HER4
FGF
FGFR1
FGFR2
  • Antibodies: Aprutumab
  • Aprutumab ixadotin
FGFR3
FGFR4
Unsorted
HGF (c-Met)
IGF
IGF-1
  • Kinase inhibitors: BMS-754807
  • Linsitinib
  • NVP-ADW742
  • NVP-AEW541
  • OSl-906
IGF-2
  • Antibodies: Dusigitumab
  • Xentuzumab (against IGF-1 and IGF-2)
Others
  • Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)
  • Trofinetide
LNGF (p75NTR)
  • Aptamers: Against NGF: RBM-004
  • Decoy receptors: LEVI-04 (p75NTR-Fc)
PDGF
RET (GFL)
GFRα1
GFRα2
GFRα3
GFRα4
Unsorted
  • Kinase inhibitors: Agerafenib
SCF (c-Kit)
TGFβ
  • See here instead.
Trk
TrkA
  • Negative allosteric modulators: VM-902A
  • Aptamers: Against NGF: RBM-004
  • Decoy receptors: ReN-1820 (TrkAd5)
TrkB
TrkC
VEGF
Others
Portal:
  • icon Biology